NALÇAKAN, H. Et Al. 2022. Molecular Docking, in silico ADMET Analyses and Computational Approach of Novel Fedratinib Derivatives as Potent JAK2 Inhibitors to Reveal Binding Potentials for Myelofibrosis (MF) Treatment. 8th International BAU Drug Design Congress - Bahçeşehir University , (İstanbul, Turkey).

NALÇAKAN, H., KURTAY, G., & GÜNGÖR, T., (2022). Molecular Docking, in silico ADMET Analyses and Computational Approach of Novel Fedratinib Derivatives as Potent JAK2 Inhibitors to Reveal Binding Potentials for Myelofibrosis (MF) Treatment . 8th International BAU Drug Design Congress - Bahçeşehir University, İstanbul, Turkey

NALÇAKAN, HARUN, GÜLBİN KURTAY, And TUĞBA GÜNGÖR. "Molecular Docking, in silico ADMET Analyses and Computational Approach of Novel Fedratinib Derivatives as Potent JAK2 Inhibitors to Reveal Binding Potentials for Myelofibrosis (MF) Treatment," 8th International BAU Drug Design Congress - Bahçeşehir University, İstanbul, Turkey, 2022

NALÇAKAN, HARUN Et Al. "Molecular Docking, in silico ADMET Analyses and Computational Approach of Novel Fedratinib Derivatives as Potent JAK2 Inhibitors to Reveal Binding Potentials for Myelofibrosis (MF) Treatment." 8th International BAU Drug Design Congress - Bahçeşehir University , İstanbul, Turkey, 2022

NALÇAKAN, H. KURTAY, G. And GÜNGÖR, T. (2022) . "Molecular Docking, in silico ADMET Analyses and Computational Approach of Novel Fedratinib Derivatives as Potent JAK2 Inhibitors to Reveal Binding Potentials for Myelofibrosis (MF) Treatment." 8th International BAU Drug Design Congress - Bahçeşehir University , İstanbul, Turkey.

@conferencepaper{conferencepaper, author={HARUN NALÇAKAN Et Al. }, title={Molecular Docking, in silico ADMET Analyses and Computational Approach of Novel Fedratinib Derivatives as Potent JAK2 Inhibitors to Reveal Binding Potentials for Myelofibrosis (MF) Treatment}, congress name={8th International BAU Drug Design Congress - Bahçeşehir University}, city={İstanbul}, country={Turkey}, year={2022}}